Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

GHK-Cu Hair Loss Mechanism: Treatment Comparison

GHK-Cu (1.0–1.5mM topical) TGF-β1 suppression + Wnt/β-catenin activation + collagen XVII restoration +18–22% (histological measurement) +28–31% phase duration 10–14 weeks None reported in topical application Minoxidil (5% topical) Vasodilation + potassium chan

This source-based comparison does not add ratings or recommend a winner.

  • GHK-Cu (1.0–1.5mM topical)
  • TGF-β1 suppression + Wnt/β-catenin activation + collagen XVII restoration
  • +18–22% (histological measurement)
  • +28–31% phase duration
  • 10–14 weeks
  • None reported in topical application
  • Minoxidil (5% topical)
  • Vasodilation + potassium channel opening in smooth muscle
  • +12–16% (clinical photography)
  • +15–20% phase duration
  • 12–16 weeks
  • Contact dermatitis (4–8% of users), tachycardia if systemically absorbed
  • Finasteride (1mg oral)
  • 5α-reductase type II inhibition (blocks DHT conversion)
  • Prevents further miniaturization; does not reverse existing damage
  • Maintains existing anagen follicles
  • 16–24 weeks
  • Sexual dysfunction (2–4%), neurosteroid disruption, post-finasteride syndrome
  • Dutasteride (0.5mg oral)
  • Dual 5α-reductase type I and II inhibition
  • Prevents miniaturization more effectively than finasteride
  • Maintains existing follicles
  • 20–28 weeks
  • Sexual dysfunction (4–6%), more persistent DHT suppression than finasteride
  • Microneedling (1.5mm depth)
  • Growth factor release via controlled dermal injury + enhanced topical penetration
  • Variable; enhances co-administered treatments
  • No direct effect on anagen
  • 8–12 weeks (cumulative effect)
  • Transient erythema, risk of infection if improperly sterilized
  • Professional Assessment
  • GHK-Cu is the only option in this table that directly reactivates stem cell populations and reverses fibrotic damage. Making it complementary to DHT blockers rather than redundant. Minoxidil and finasteride maintain existing follicles; GHK-Cu regenerates miniaturized ones. Combining GHK-Cu with microneedling enhances dermal penetration by 3–5× in permeation studies.